C4 Therapeutics Inc

XNAS: CCCC

Weak Stock

Download real time

1.25 0.15 (13.64%)

83.68% Fall from 52W High

1.8M XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

88.7

Market Cap

Below industry Median

0.3

Beta 1Year

Very Low volatility

C4 Therapeutics Inc - CCCC - stock price prediction, stock price target, analyst ratings from 9 analysts

C4 Therapeutics Inc has a share price target of US$ 16, revenue growth forecast of -32.0%, and profit growth estimate of -38.9% for FY25, based on top 9 analyst calls.

Forecaster Screeners